Lundbeck
HLUN-B.CO
$4.36
Share price
-0.83%
Change (1 day)
-6.24%
Change (1 year)
Categories
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.
Lundbeck (HLUN-B.CO) - Total debt
Total debt on the balance sheet as of December 2024 : $2.32 Billion USD
According to Lundbeck 's latest financial reports the company's total debt is $2.32 Billion USD. A company’s total debt is the sum of all current and non-current debts.
Lundbeck - Total debt on balance sheet (from 2009 to 2024)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-12-31 | $2.32 B | 278.87% |
| 2023-12-31 | $0.61 B | -23.48% |
| 2022-12-31 | $0.80 B | -0.85% |
| 2021-12-31 | $0.81 B | -37.87% |
| 2020-12-31 | $1.30 B | -9.18% |
| 2019-12-31 | $1.43 B | |
| 2018-12-31 | N/A | -100% |
| 2017-12-31 | $9.18 M | -96.58% |
| 2016-12-31 | $0.26 B | -51.41% |
| 2015-12-31 | $0.55 B | 1.19% |
| 2014-12-31 | $0.54 B | 36.53% |
| 2013-12-31 | $0.39 B | 18.14% |
| 2012-12-31 | $0.33 B | 1.2% |
| 2011-12-31 | $0.33 B | -2.89% |
| 2010-12-31 | $0.34 B | -48.55% |
| 2009-12-31 | $0.66 B | 87.23% |
| 2008-12-31 | $0.35 B | -1.97% |
| 2007-12-31 | $0.36 B | 43.55% |
| 2006-12-31 | $0.25 B | 317.99% |
| 2005-12-31 | $60.78 M | -18.62% |
| 2004-12-31 | $74.69 M |